尼可地尔对猪心脏骤停后心肌损伤的保护作用
[Abstract]:Background: advances in resuscitation have significantly increased the recovery rate of autonomic circulation, but the incidence and mortality of cardiac arrest remain high. Cardiac dysfunction after resuscitation was the main cause of high mortality within 72 hours after cardiac arrest. Although cardiac dysfunction after resuscitation is considered to be temporary, it is associated with decreased arterial blood pressure and low cardiac output after cardiac arrest. Intervention aimed at improving cardiac dysfunction after resuscitation may benefit clinical practice. As a ATP sensitive potassium channel opener, nicorandil is a standard drug for the treatment of coronary artery disease. Both basic and clinical studies have shown that nicorandil can improve the systolic dysfunction of the heart after ischemia and reduce myocardial infarction size after coronary artery occlusion and reperfusion. However, there are few studies on the application of nicordil in cardiac arrest and resuscitation models. Aim: to investigate the protective effect of nicorandil on myocardial injury after resuscitation in porcine cardiac arrest model induced by 4min ventricular fibrillation. Methods: 20 Landrace pigs were randomly divided into two groups: sham operation group (n = 4) and resuscitation group (n = 16). In the resuscitation group, electrical stimulation was given to induce ventricular fibrillation and cardiopulmonary resuscitation was performed after 4min. The sham group was given surgery without inducing ventricular fibrillation. Sixteen Landrace pigs in the resuscitation group were successfully resuscitated and randomly divided into two groups: saline control group (n = 8) and nicorandil group (n = 8). Nicodil (150 渭 g/kg) was immediately injected via central vein in nicorandil group. Then 3 渭 g / (kg min) was given intravenously to the end of reperfusion. Saline control group was given the same dose of normal saline. Continuous monitoring of hemodynamic parameters during the experiment: heart rate, mean arterial pressure, cardiac output, dp/dtmax and-dp/dtmax. Blood samples were taken to detect troponin I and lactate levels before fibrillation and after recovery of autonomic circulation. Left ventricular ejection fraction (LVEF) was evaluated by echocardiography before fibrillation and 6 hours after spontaneous circulation recovery. Euthanasia was performed 6 hours after the recovery of autonomic circulation and myocardial tissue was taken. The histological damage of myocardium was observed by general pathology and transmission electron microscopy. Apoptotic cardiomyocytes were detected by TUNEL method. The expression of Bax,caspase-3 and Bcl-2 in myocardial tissue was detected by ELISA and, Western Blot. Results: compared with saline control group, nicorandil significantly improved hemodynamic parameters except-dp/dtmax and heart rate (P0.05) at 6 h after recovery of autonomic circulation (P0.05). Compared with the sham operation group, the level of troponin I and lactate in saline control group increased after successful resuscitation, but the level of nicorandil group decreased significantly (P0.05). Compared with the sham operation group, the concentration of ATP in the saline control group was significantly lower than that in the nicorandil group (P0.05). Compared with the saline control group, the myocardial tissue injury and the number of TUNEL positive cells decreased after resuscitation in the nicorandil group (P0.05). The expression of Bax and caspase-3 decreased and the expression of Bcl-2 increased in the myocardium of nicorandil group. The difference was statistically significant (P0.05). Conclusion: nicorandil can improve cardiac dysfunction and energy metabolism after resuscitation, alleviate myocardial tissue injury and anti-apoptosis, and thus protect myocardium from cardiac arrest.
【学位授予单位】:山东大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R541.78
【相似文献】
相关期刊论文 前10条
1 靳三庆,黄文起,陈秉学,徐颖琦,朱艳玲,黄伟明,王治平,顾勇,金沐,华海音,杨广;尼可地尔停跳心脏效果的初步研究[J];广东医学;1999年12期
2 李世康,龙村,程邦昌,何巍,刘唐威;尼可地尔对改善冠状动脉内皮细胞低温保存的作用[J];中华器官移植杂志;2002年06期
3 李莉;心肌缺血治疗中的钾离子通道开放剂尼可地尔的强效治疗作用[J];国外医学.药学分册;2002年04期
4 李世康,龙村,程邦昌,何巍,刘唐威,姜浩;低温下尼可地尔对冠状动脉内皮细胞功能的影响(英文)[J];中国临床康复;2004年33期
5 何蕾,骆荩,马淑景,李佳春,江朝光;尼可地尔对心肌功能的保护作用研究[J];中国体外循环杂志;2005年02期
6 吴文利,梅霞,罗羽慧;尼可地尔治疗冠心病稳定型心绞痛68例[J];中国药业;2005年05期
7 赵京林,杨跃进,尤士杰,荆志成,吴永健,杨伟宪,孟亮,田毅,陈纪林,高润霖,陈在嘉;尼可地尔对猪急性心肌梗死再灌注后无再流的影响[J];中国危重病急救医学;2005年07期
8 鹿欣;刘立群;陈维宁;崔玉倩;王士忠;都彩菊;;尼可地尔后处理联合预处理对离体心肌缺血/再灌注的作用研究[J];中华临床医师杂志(电子版);2007年06期
9 李海亮;;尼可地尔治疗冠心病稳定型心绞痛72例临床分析[J];中国社区医师(医学专业半月刊);2008年09期
10 刘亚楠;王斌;;尼可地尔治疗老年不稳定型心绞痛的临床观察[J];临床荟萃;2011年22期
相关会议论文 前4条
1 张颖;;尼可地尔、美托洛尔、谷氨酰胺单独及联合使用抗大鼠心肌缺血/再灌注损伤的保护作用[A];中华医学会第十五次全国心血管病学大会论文汇编[C];2013年
2 胡元汉;陈嘉莹;;尼可地尔联合美托洛尔治疗不稳定型心绞痛的临床疗效[A];中华医学会第十五次全国心血管病学大会论文汇编[C];2013年
3 李斌;;尼可地尔对冠脉慢血流患者脂联素及超敏C反应蛋白[A];中华医学会第十五次全国心血管病学大会论文汇编[C];2013年
4 张颖;;尼可地尔、美托洛尔、谷氨酰胺单独及联合用药对大鼠心肌缺血/再灌注损伤后心肌细胞抗凋亡能力和保护性蛋白HSP70表达的影响[A];中华医学会第十五次全国心血管病学大会论文汇编[C];2013年
相关博士学位论文 前6条
1 陈春红;山莨菪碱联合尼可地尔对STEMI直接PCI患者心肌再灌注的保护性研究[D];河北医科大学;2015年
2 张颖倩;尼可地尔抑制大鼠颈动脉球囊拉伤后内膜增生及促进内皮化的研究[D];中国人民解放军医学院;2016年
3 樊延明;经桡动脉冠状动脉介入治疗对桡动脉结构和功能影响的系列研究[D];河北医科大学;2017年
4 罗碧辉;尼可地尔临床疗效的系统评价[D];南方医科大学;2013年
5 李悦玮;尼可地尔后处理对大鼠心肌缺血损伤的保护作用及机制研究[D];吉林大学;2013年
6 赵京林;急性心肌梗死再灌注后无再流及药物干预的实验研究[D];中国协和医科大学;2005年
相关硕士学位论文 前10条
1 钟昊;尼可地尔保存液对静脉移植物保护作用的研究[D];河北医科大学;2015年
2 罗平;尼可地尔缓释片制备工艺及其体内外释药研究[D];湖北中医药大学;2015年
3 王明磊;阿托伐他汀和尼可地尔治疗冠状动脉慢血流的临床研究[D];青岛大学;2015年
4 阎艳红;尼可地尔治疗冠脉部分血运重建后心绞痛的临床疗效观察[D];山西医科大学;2016年
5 惠强;尼可地尔对阿霉素大鼠急性心肌损伤的干预作用[D];广西医科大学;2016年
6 陈云顺;尼可地尔预处理对大鼠缺血再灌注心肌mtDNA4834bp片段缺失的影响[D];青岛大学;2016年
7 高希磊;尼可地尔对稳定性微血管病性心绞痛的疗效观察[D];青岛大学;2016年
8 刘丽丽;尼可地尔预处理对大鼠心肌缺血再灌注氧化应激及炎性因子影响的研究[D];河北医科大学;2016年
9 冯敏;尼可地尔脉冲迟释片制备及其体内外释药研究[D];湖北中医药大学;2016年
10 王永乐;尼可地尔在急性非ST抬高心肌梗死介入治疗后对心血管事件的影响[D];新乡医学院;2016年
,本文编号:2397082
本文链接:https://www.wllwen.com/yixuelunwen/xxg/2397082.html